학술논문
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15548635